OVERVIEW
Lung cancer treatment is rapidly evolving. The special edition of the Conference “The best of the year in lung cancer ” will provide current and practical information on the treatment of lung cancer, as well as a look at the novel agents and strategies with the potential to shape the future of lung cancer therapy. Leading national and international experts will share their knowledge and perspectives on the management of thoracic malignancies, in order to disseminate education and improving the best practice of Italian lung cancer specialists.
This Congress will allow Experts and participants to discuss the latest findings, put them into context and really understand how they affect our practice day to day.
Participants will gain the opportunity to engage with faculty as they will share their point of view and personal experiences about the clinical challenges and ongoing controversies in lung cancer management.
TARGET AUDIENCE
This educational meeting is directed toward medical, surgical and radiation oncologists interested in the treatment of patients with lung cancer.
Nurses, Pharmacists, Physicians, researchers and other healthcare professionals interested in the treatment of lung cancer are also welcome.
LEARNING OBJECTIVES
The best treatment for non oncogene addicted and oncogene addicted Non Small Cell Lung cancer.
Overview of the major area of research for target therapies and for immunotherapy.
OFFICIAL LANGUAGE
The official language is English.
PRESIDENT
Marina Chiara Garassino
Chief of Thoracic Oncology
Oncologia Medica Toracico-Polmonare Fondazione IRCCS
Istituto Nazionale dei Tumori, Milano
PRESIDENT
Marina Chiara Garassino
Chief of Thoracic Oncology
Oncologia Medica Toracico-Polmonare Fondazione IRCCS
Istituto Nazionale dei Tumori, Milano
PRESIDENT
Marina Chiara Garassino
Chief of Thoracic Oncology
Oncologia Medica Toracico-Polmonare Fondazione IRCCS
Istituto Nazionale dei Tumori, Milano
